Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Oligometastatic Disease × Tretinoin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Leukemia, Myeloid, Acute 5 Myelodysplastic Syndromes 3 Multiple Myeloma 3 Melanoma 2 Recurrence 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Parkinson Disease 4, Autosomal Dominant Lewy Body 1 Oligometastatic Disease 1 Neoplasms, Plasma Cell 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Mantle-Cell 1 Lymphoma, Large-Cell, Immunoblastic 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma, Follicular 1 Lymphoma 1 Leukemia, Promyelocytic, Acute 1 Leukemia 1 Hodgkin Disease 1 Burkitt Lymphoma 1 Blast Crisis 1 Anemia, Refractory, with Excess of Blasts 1

Interventions

Tretinoin 1 Radiosurgery 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06439888 2025-12-01

LySATRA

Gustave Roussy, Cancer Campus, Grand Paris

Phase 1/2 Recruiting

Other solid neoplasm

Oligometastatic Disease

Data powered by HemOnc (CC BY 4.0) Colophon ⚡